BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 8549623)

  • 1. Stimulation of spinal delta-opioid receptors in mice selectively enhances the attenuation of delta-opioid receptor-mediated antinociception by antisense oligodeoxynucleotide.
    Narita M; Tseng LF
    Eur J Pharmacol; 1995 Sep; 284(1-2):185-9. PubMed ID: 8549623
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antisense oligodeoxynucleotide to a delta-opioid receptor messenger RNA selectively blocks the antinociception induced by intracerebroventricularly administered delta-, but not mu-, epsilon- or kappa-opioid receptor agonists in the mouse.
    Wang HQ; Kampine JP; Tseng LF
    Neuroscience; 1996 Nov; 75(2):445-52. PubMed ID: 8931008
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pretreatment with beta-endorphin facilitates the attenuation of delta-opioid receptor-mediated antinociception caused by delta-opioid receptor antisense oligodeoxynucleotide.
    Tseng LF; Narita M; Kampine JP
    Eur J Pharmacol; 1995 Dec; 287(2):169-72. PubMed ID: 8749031
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of pretreatment with a delta 2-opioid receptor antisense oligodeoxynucleotide on the recovery from acute antinociceptive tolerance to delta 2-opioid receptor agonist in the mouse spinal cord.
    Narita M; Mizoguchi H; Kampine JP; Tseng LF
    Br J Pharmacol; 1997 Feb; 120(4):587-92. PubMed ID: 9051295
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of antisense oligodeoxynucleotide to delta-opioid receptor mRNA in the study of turnover of delta-opioid receptors in the spinal cord of the mouse.
    Narita M; Mizoguchi H; Nagase H; Tseng LF
    Psychopharmacology (Berl); 1997 Oct; 133(4):347-50. PubMed ID: 9372533
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antisense oligodeoxynucleotide to a delta-opioid receptor selectively blocks the spinal antinociception induced by delta-, but not mu- or kappa-opioid receptor agonists in the mouse.
    Tseng LF; Collins KA; Kampine JP
    Eur J Pharmacol; 1994 Jun; 258(1-2):R1-3. PubMed ID: 7925585
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antisense oligodeoxynucleotide to a delta-opioid receptor blocks the antinociception induced by cold water swimming.
    Mizoguchi H; Narita M; Nagase H; Tseng LF
    Regul Pept; 1995 Oct; 59(2):255-9. PubMed ID: 8584762
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of protein kinase C in desensitization of spinal delta-opioid-mediated antinociception in the mouse.
    Narita M; Mizoguchi H; Kampine JP; Tseng LF
    Br J Pharmacol; 1996 Aug; 118(7):1829-35. PubMed ID: 8842450
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Selective inhibition of [D-Ala2, Glu4]deltorphin antinociception by supraspinal, but not spinal, administration of an antisense oligodeoxynucleotide to an opioid delta receptor.
    Bilsky EJ; Bernstein RN; Pasternak GW; Hruby VJ; Patel D; Porreca F; Lai J
    Life Sci; 1994; 55(2):PL37-43. PubMed ID: 8015351
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Delta-1 opioid receptor-mediated antinociceptive properties of a nonpeptidic delta opioid receptor agonist, (-)TAN-67, in the mouse spinal cord.
    Tseng LF; Narita M; Mizoguchi H; Kawai K; Mizusuna A; Kamei J; Suzuki T; Nagase H
    J Pharmacol Exp Ther; 1997 Feb; 280(2):600-5. PubMed ID: 9023269
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Selective blockade of peripheral delta opioid agonist induced antinociception by intrathecal administration of delta receptor antisense oligodeoxynucleotide.
    Bilsky EJ; Wang T; Lai J; Porreca F
    Neurosci Lett; 1996 Dec; 220(3):155-8. PubMed ID: 8994216
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential effects of antisense oligodeoxynucleotides directed against g(zalpha) and g(oalpha) on antinociception produced by spinal opioid and alpha(2) adrenergic receptor agonists.
    Karim F; Roerig SC
    Pain; 2000 Aug; 87(2):181-191. PubMed ID: 10924811
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of antinociception to opioid receptor selective agonists after antisense oligodeoxynucleotide-mediated "knock-down" of opioid receptor in vivo.
    Bilsky EJ; Bernstein RN; Hruby VJ; Rothman RB; Lai J; Porreca F
    J Pharmacol Exp Ther; 1996 Apr; 277(1):491-501. PubMed ID: 8613959
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of antisense oligodeoxynucleotide to determine delta-opioid receptor involvement in [D-Ala2]deltorphin II-induced locomotor hyperactivity.
    Mizoguchi H; Narita M; Nagase H; Suzuki T; Quock RM; Tseng LF
    Life Sci; 1996; 59(4):PL69-73. PubMed ID: 8761010
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antisense oligodeoxynucleotide to a delta-opioid receptor given intrathecally blocks i.c.v. administered beta-endorphin-induced antinociception in the mouse.
    Tseng LF; Collins KA
    Life Sci; 1994; 55(7):PL127-31. PubMed ID: 8041224
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interaction between the mu-agonist dermorphin and the delta-agonist [D-Ala2, Glu4]deltorphin in supraspinal antinociception and delta-opioid receptor binding.
    Negri L; Improta G; Lattanzi R; Potenza RL; Luchetti F; Melchiorri P
    Br J Pharmacol; 1995 Dec; 116(7):2931-8. PubMed ID: 8680727
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of the phosphatidylinositol-specific phospholipase C pathway in delta-opioid receptor-mediated antinociception in the mouse spinal cord.
    Narita M; Ohsawa M; Mizoguchi H; Aoki T; Suzuki T; Tseng LF
    Neuroscience; 2000; 99(2):327-31. PubMed ID: 10938438
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nonopioidergic mechanism mediating morphine-induced antianalgesia in the mouse spinal cord.
    Wu HE; Thompson J; Sun HS; Leitermann RJ; Fujimoto JM; Tseng LF
    J Pharmacol Exp Ther; 2004 Jul; 310(1):240-6. PubMed ID: 14999057
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Buprenorphine blocks epsilon- and micro-opioid receptor-mediated antinociception in the mouse.
    Mizoguchi H; Spaulding A; Leitermann R; Wu HE; Nagase H; Tseng LF
    J Pharmacol Exp Ther; 2003 Jul; 306(1):394-400. PubMed ID: 12721333
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Involvement of spinal protein kinase Cgamma in the attenuation of opioid mu-receptor-mediated G-protein activation after chronic intrathecal administration of [D-Ala2,N-MePhe4,Gly-Ol(5)]enkephalin.
    Narita M; Mizoguchi H; Narita M; Nagase H; Suzuki T; Tseng LF
    J Neurosci; 2001 Jun; 21(11):3715-20. PubMed ID: 11356858
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.